Topical Minocycline Foam (FMX-103) for the Treatment of Moderate-to-Severe Rosacea: Results of a Phase 2, Randomized, Double-Blind, Multicenter Clinical Study

Main Article Content

Ulrich Mrowietz
Tal Hetzroni Kedem
Rita Kenyan
Meir Eini
Dov Tamarkin
Mitchell Shirvan

Keywords

rosacea, minocycline, randomized, clinical trial

Abstract

Abstract Not Available